Targeting CXCL8 signaling sensitizes HNSCC to anlotinib by reducing tumor-associated macrophage-derived CLU
2025 · Journal of Experimental & Clinical Cancer Research · 8 citations
https://doi.org/10.1186/s13046-025-03298-7
Y
Yikang Ji
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
143
Citations
6
h-index
3
i10-index
Yikang Ji is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Cancer Research and Treatments. The author has an h-index of 6, co-authored 44 publications.
ORCID: 0009-0002-0950-9383Papers by this author
worksExperimental research on the feasibility of phosphogypsum-enzyme induced carbonate precipitation (EICP) solidified loess
2025 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-025-15229-9
Supplement figure 1 from Tumor-Derived RAB21<sup>+</sup>ABHD12<sup>+</sup> sEVs Drive the Premetastatic Microenvironment in the Lung
2024 · 0 citations
https://doi.org/10.1158/2326-6066.25132759.v1
Supplementary table 1 from Tumor-Derived RAB21<sup>+</sup>ABHD12<sup>+</sup> sEVs Drive the Premetastatic Microenvironment in the Lung
2024 · 0 citations
https://doi.org/10.1158/2326-6066.25132732.v1
Supplement figure 2 from Tumor-Derived RAB21<sup>+</sup>ABHD12<sup>+</sup> sEVs Drive the Premetastatic Microenvironment in the Lung
2024 · 0 citations
https://doi.org/10.1158/2326-6066.25132756.v1
Supplement figure 4 from Tumor-Derived RAB21<sup>+</sup>ABHD12<sup>+</sup> sEVs Drive the Premetastatic Microenvironment in the Lung
2024 · 0 citations
https://doi.org/10.1158/2326-6066.25132750
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat